GDTC
CytoMed Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · SG
$0.86
−2.15%Margins
Gross margin
-20.5%
EBITDA margin
-820.3%
EBIT margin
-672.2%
Net margin
-754.7%
FCF margin
-986.0%
-74.1%
Return on equity
-60.7%
Return on assets
-61.5%
Return on invested capital
0.08x
Asset turnover
-$4.3M
Cash from operations
$0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025